MercyOne Waterloo Cancer Center is a clinical research site located in Waterloo, Iowa, United States 50702.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
MercyOne Waterloo Cancer Center has participated in 23 clinical trials with 18 currently active.
Therapeutic areas: Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Iowa · View every site in Waterloo
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MercyOne Waterloo Cancer Center has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MercyOne Waterloo Cancer Center has 23 clinical trials on record, with 18 currently active. Their work covers Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.
MercyOne Waterloo Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.